iBio, Inc.
IBIO
$1.26
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -75.00% | -20.00% | -20.00% | 185.71% | 77.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -75.00% | -20.00% | -20.00% | 185.71% | 77.78% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -75.00% | -20.00% | -20.00% | 185.71% | 77.78% |
| SG&A Expenses | -0.89% | 36.41% | 19.65% | -4.92% | -8.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.13% | 70.23% | 61.74% | 32.48% | 12.71% |
| Operating Income | -62.01% | -72.24% | -63.71% | -30.76% | -11.83% |
| Income Before Tax | -79.81% | -67.72% | -73.79% | -40.05% | -19.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.81% | -67.72% | -73.79% | -40.05% | -19.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.81% | -31.51% | -28.15% | 13.14% | 26.22% |
| EBIT | -62.01% | -72.24% | -63.71% | -30.76% | -11.83% |
| EBITDA | -65.43% | -76.55% | -68.18% | -33.34% | -13.51% |
| EPS Basic | 71.03% | 65.59% | 54.33% | 75.62% | 83.68% |
| Normalized Basic EPS | 72.94% | 55.56% | 46.32% | 61.76% | 77.63% |
| EPS Diluted | 71.03% | 65.59% | 54.34% | 75.62% | 83.68% |
| Normalized Diluted EPS | 72.94% | 55.56% | 46.32% | 61.76% | 77.63% |
| Average Basic Shares Outstanding | 813.33% | 598.12% | 375.87% | 132.83% | 173.73% |
| Average Diluted Shares Outstanding | 813.33% | 598.12% | 375.87% | 132.83% | 173.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |